Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2010477 | Pharmacological Reports | 2014 | 8 Pages |
Abstract
The hyperalgesic and allodynic actions of locally treated remifentanil may decrease in diabetic conditions. Increases in NMDA receptors activation, reactive oxygen species production and NO release may modify the sensitivity to remifentanil in diabetes induced neuropathic pain states.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Tufan Mert, Hafize Oksuz, Berin Tugtag, Metin Kilinc, Nimet Senoglu, Ramazan Bilgin,